Piauhy | Medical Cannabis | Natural Medicinal Innovation made in Portugal
parallax background

Transforming and innovating the
Medicinal Cannabis industry to
generate substantial and positive
changes to the patients' lives.

Transforming and innovating the Medicinal Cannabis industry to generate substantial and positive changes to the patients' lives.

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

RESEARCH | R&D

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.



 
alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer
 

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.



3

CANNABIS APPLICATIONS

alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

NEWS

NEWS

May 20, 2022

Agorà Conference 2022 | The future of neurosciences and mental disorders

Are phytocannabinoids the future of human health? Are psychedelics the future treatments for mental disorders? What are their potential for Autism? What role does the pluriverse […]
February 11, 2022

Cannabis sativa and its use in fighting cancer – Piauhy Labs

Autism is a psychiatric problem that is usually identified in childhood, between 1 year and a half and 3 years, although the initial signs sometimes appear […]
February 4, 2022

Cannabis sativa and its use in the treatment of Autistic Spectrum Disorder

Autism is a psychiatric problem that is usually identified in childhood, between 1 year and a half and 3 years, although the initial signs sometimes appear […]
 
 
 

JOIN OUR NEWSLETTER

 
Investor